Tissue culture antiviral processes and compositions

Details Tissue culture antiviral processes and compositions Tissue culture antiviral processes and compositions

1989-11-07

1991-05-28

Rosen, Sam

Chemistry: molecular biology and microbiology

Differentiated tissue or organ other than blood, per se, or...

Including perfusion; composition therefor

435 2, 4352351, 4352401, 4352402, A01N 102, C12N 500

Patent

active

050194950

ABSTRACT:
Nutrient, such as fetal calf serum, for tissue culture medium comprising serum and one or more glycyrrhizic triterpenoid compounds and delipidated albumin to inactivate BVD, CMV and other susceptible viruses and processes of protecting tissue cultures from viral infection are disclosed.

REFERENCES:
Pompei et al.,-Chem. Abst., vol. 92 (1980), p. 191,170n.
Pompei et al.,-Chem. Abst., vol. 92 (1980), p. 122,494j.
Pompei et al.,-Nature (London), vol. 281, (Oct. 1979), pp. 689-690.
Pompei et al.,-Experientia, vol. 36, No. 3, (1980), p. 304.

Affiliated with

Also associated with

Rating

Tissue culture antiviral processes and compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tissue culture antiviral processes and compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tissue culture antiviral processes and compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-35648